Dimensional Fund Advisors LP Harmony Biosciences Holdings, Inc. Transaction History

Dimensional Fund Advisors LP

$391 Billion
Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,224,794 shares of HRMY stock, worth $41.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,224,794

Previous 1,213,029 0.97%

Holding current value

$41.9 Million

Previous $41.7 Million 2.61%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$32.18 - $40.46 $378,597 - $476,011	11,765 Added 0.97%	1,224,794 $40.7 Million
Q4 2024 Feb 13, 2025	BUY	$31.86 - $41.49 $5.11 Million - $6.66 Million	160,490 Added 15.25%	1,213,029 $41.7 Million
Q3 2024 Nov 07, 2024	BUY	$30.0 - $39.95 $2.87 Million - $3.83 Million	95,754 Added 10.01%	1,052,539 $42 Million
Q2 2024 Aug 09, 2024	BUY	$28.81 - $33.01 $3.23 Million - $3.7 Million	112,197 Added 13.28%	956,785 $28.9 Million
Q1 2024 May 10, 2024	BUY	$29.93 - $35.06 $3.24 Million - $3.8 Million	108,320 Added 14.71%	844,588 $28.4 Million
Q4 2023 Feb 07, 2024	SELL	$19.2 - $33.78 $924,979 - $1.63 Million	-48,176 Reduced 6.14%	736,268 $23.8 Million
Q3 2023 Nov 09, 2023	BUY	$31.89 - $39.03 $1.65 Million - $2.03 Million	51,893 Added 7.08%	784,444 $25.7 Million
Q2 2023 Aug 09, 2023	SELL	$30.5 - $37.4 $3.03 Million - $3.72 Million	-99,476 Reduced 11.96%	732,551 $25.8 Million
Q1 2023 May 12, 2023	BUY	$30.8 - $53.92 $7.75 Million - $13.6 Million	251,623 Added 43.35%	832,027 $27.2 Million
Q4 2022 Feb 09, 2023	BUY	$45.4 - $60.91 $800,583 - $1.07 Million	17,634 Added 3.13%	580,404 $32 Million
Q3 2022 Nov 10, 2022	BUY	$42.06 - $55.45 $4.42 Million - $5.83 Million	105,082 Added 22.96%	562,770 $24.9 Million
Q2 2022 Aug 12, 2022	BUY	$33.54 - $52.15 $3.74 Million - $5.82 Million	111,636 Added 32.26%	457,688 $22.3 Million
Q1 2022 May 13, 2022	BUY	$33.14 - $51.13 $5 Million - $7.72 Million	150,931 Added 77.35%	346,052 $16.8 Million
Q4 2021 Feb 09, 2022	BUY	$34.09 - $43.91 $5.41 Million - $6.97 Million	158,725 Added 436.11%	195,121 $8.32 Million
Q3 2021 Nov 12, 2021	BUY	$25.68 - $38.61 $934,649 - $1.41 Million	36,396 New	36,396 $1.4 Million

Others Institutions Holding HRMY

# of Institutions

278

Shares Held

44.9M

Call Options Held

130K

Put Options Held

46.5K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Harmony Biosciences Holdings, Inc. Transaction History